# Phygen, LLC: Form D filings

Phygen, LLC, a biotechnology company in Irvine, CA, filed 2 Form D notices with the SEC in 2018. The latest, on May 3, 2018, reports an offering of no set size with nothing sold yet.

Find out what Phygen, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Phygen%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Phygen%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fphygen-llc-1736890)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Phygen%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Phygen%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fphygen-llc-1736890)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2301 DUPONT DRIVE, SUITE 110, Irvine, CA, 92612
- Phone: (949) 752-7885
- Industry: Biotechnology
- Entity type: Limited Liability Company
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1736890

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 3, 2018 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1736890/000173689018000002/0001736890-18-000002-index.htm) |
| Apr 11, 2018 | New notice | $3,000,000 | $2,000,000 | $1,000,000 | 1 | Apr 7, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1736890/000173689018000001/0001736890-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Tom Kula | Director |  |
| Amir David Tahernia | Director |  |
| Thomas David Gardner | Executive Officer, Director |  |
| Lee Kelley | Director |  |
| Mark Renfro | Director |  |
| Ben Guiot | Director |  |
| Frank David Kuwamura | Director |  |
| Mark David Selawski | Executive Officer |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026

[Every Form D from the week of Apr 30, 2018](https://specstream.ai/data/form-d/week/2018-04-30) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Phygen, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).